142 related articles for article (PubMed ID: 30853937)
1. Characterization of the EM66 Biomarker in the Pituitary and Plasma of Healthy Subjects With Different Gonadotroph Status and Patients With Gonadotroph Tumor.
Guillemot J; Guérin M; Cailleux AF; Lopez AG; Kuhn JM; Anouar Y; Yon L
Front Endocrinol (Lausanne); 2019; 10():102. PubMed ID: 30853937
[TBL] [Abstract][Full Text] [Related]
2. Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma.
Guillemot J; Anouar Y; Montero-Hadjadje M; Grouzmann E; Grumolato L; Roshmaninho-Salgado J; Turquier V; Duparc C; Lefebvre H; Plouin PF; Klein M; Muresan M; Chow BK; Vaudry H; Yon L
Int J Cancer; 2006 Apr; 118(8):2003-12. PubMed ID: 16287097
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
[TBL] [Abstract][Full Text] [Related]
4. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.
Yon L; Guillemot J; Montero-Hadjadje M; Grumolato L; Leprince J; Lefebvre H; Contesse V; Plouin PF; Vaudry H; Anouar Y
J Clin Endocrinol Metab; 2003 Jun; 88(6):2579-85. PubMed ID: 12788858
[TBL] [Abstract][Full Text] [Related]
5. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization and immunocytochemical localization of EM66, a novel peptide derived from secretogranin II, in the rat pituitary and adrenal glands.
Montero-Hadjadje M; Pelletier G; Yon L; Li S; Guillemot J; Magoul R; Tillet Y; Vaudry H; Anouar Y
J Histochem Cytochem; 2003 Aug; 51(8):1083-95. PubMed ID: 12871990
[TBL] [Abstract][Full Text] [Related]
7. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterisation and immunohistochemical localisation of the secretogranin II-derived peptide EM66 in the hypothalamus of the jerboa (Jaculus orientalis): modulation by food deprivation.
Boutahricht M; Guillemot J; Montero-Hadjadje M; Bellafqih S; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
J Neuroendocrinol; 2005 Jun; 17(6):372-8. PubMed ID: 15929742
[TBL] [Abstract][Full Text] [Related]
9. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
[TBL] [Abstract][Full Text] [Related]
10. Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells.
Guillemot J; Aït-Ali D; Turquier V; Montero-Hadjadje M; Fournier A; Vaudry H; Anouar Y; Yon L
Regul Pept; 2006 Nov; 137(1-2):79-88. PubMed ID: 16963134
[TBL] [Abstract][Full Text] [Related]
11. A potential role for the secretogranin II-derived peptide EM66 in the hypothalamic regulation of feeding behaviour.
Trebak F; Dubuc I; Arabo A; Alaoui A; Boukhzar L; Maucotel J; Picot M; Cherifi S; Duparc C; Leprince J; Prévost G; Anouar Y; Magoul R; Chartrel N
J Neuroendocrinol; 2017 Mar; 29(3):. PubMed ID: 28166374
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: a comparative study with jerboa.
Boutahricht M; Guillemot J; Montero-Hadjadje M; Barakat Y; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
Neurosci Lett; 2007 Mar; 414(3):268-72. PubMed ID: 17240057
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary.
Miller GM; Alexander JM; Klibanski A
J Clin Endocrinol Metab; 1996 Jan; 81(1):80-3. PubMed ID: 8550798
[TBL] [Abstract][Full Text] [Related]
14. Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas.
Guillemot J; Barbier L; Thouennon E; Vallet-Erdtmann V; Montero-Hadjadje M; Lefebvre H; Klein M; Muresan M; Plouin PF; Seidah N; Vaudry H; Anouar Y; Yon L
Ann N Y Acad Sci; 2006 Aug; 1073():527-32. PubMed ID: 17102121
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical distribution of EM66 within the hypothalamic parvocellular paraventricular nucleus: colocalization with CRH and TRH but no plasticity related to acute stress and thyroidectomy in the rat.
El Yamani FZ; Yon L; Guérin M; El Ouezzani S; Alaoui A; Chartrel N; Anouar Y; Magoul R
Regul Pept; 2013 Mar; 182():28-34. PubMed ID: 23333484
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel secretogranin II-derived peptide (SgII(187-252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide.
Anouar Y; Desmoucelles C; Yon L; Leprince J; Breault L; Gallo-Payet N; Vaudry H
J Clin Endocrinol Metab; 1998 Aug; 83(8):2944-51. PubMed ID: 9709974
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel secretogranin II-derived peptide in the adult and fetal human adrenal gland.
Anouar Y; Yon L; Desmoucelles C; Leprince J; Breault L; Gallo-Payet N; Vaudry H
Endocr Res; 1998; 24(3-4):731-6. PubMed ID: 9888568
[TBL] [Abstract][Full Text] [Related]
18. Gonadotroph-lactotroph associations and expression of prolactin receptors in the equine pituitary gland throughout the seasonal reproductive cycle.
Gregory SJ; Brooks J; McNeilly AS; Ingleton PM; Tortonese DJ
J Reprod Fertil; 2000 Jul; 119(2):223-31. PubMed ID: 10864834
[TBL] [Abstract][Full Text] [Related]
19. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
20. Effect of food deprivation on the hypothalamic gene expression of the secretogranin II-derived peptide EM66 in rat.
Trebak F; Dubuc I; Picot M; Alaoui A; Leprince J; Prévost G; Anouar Y; Magoul R; Chartrel N
Neuroreport; 2017 Nov; 28(16):1049-1053. PubMed ID: 28902709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
